Ifraid Tablet (Itopride Hydrochloride)

Adult dosage

○ Adults: Administer itopride hydrochloride 50 mg orally three times daily before meals. Reduce the dose as appropriate according to symptoms.

This medication should not be used in patients who have had hypersensitivity reactions to this drug or its components. It should also not be administered to patients where gastrointestinal stimulation may be harmful, such as those with gastrointestinal bleeding, mechanical obstruction, or perforation. This medication contains lactose; therefore, it should not be used in patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. During the use of this medication, serious allergic reactions such as shock or anaphylaxis may occur, so symptoms should be closely monitored. If symptoms such as decreased blood pressure, shortness of breath, laryngeal edema, hives, pallor, and sweating occur, the medication should be stopped immediately and appropriate treatment should be sought. Since liver dysfunction or jaundice symptoms may appear, regular liver function tests should be conducted, and if abnormalities are found, the medication should be discontinued. Gastrointestinal side effects may include nausea, diarrhea, constipation, abdominal pain, and increased salivation. Neurological side effects may include headache, anxiety, sleep disturbances, and dizziness, so caution is advised. Endocrine side effects may present as gynecomastia or increased prolactin levels, thus consulting a physician is necessary if any abnormal symptoms appear. Hematological issues such as thrombocytopenia or leukopenia may occur, requiring regular blood tests. Renal and liver function tests should also be conducted regularly to check for abnormalities. This medication enhances acetylcholine activity, necessitating caution regarding interactions with other medications related to acetylcholine. Particularly when used in conjunction with anticholinergics, the effectiveness of this medication may be reduced, requiring adjustments in dosing intervals. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, as its safety has not been established. During breastfeeding, this medication may be excreted in breast milk; therefore, it should be avoided if possible, and if it must be used, breastfeeding should be stopped. Safety in pediatric populations has not been sufficiently confirmed, so it should be used with caution. Elderly patients may experience adverse reactions more easily due to decreased bodily functions, so symptoms should be closely monitored, and dosage adjustments or discontinuation should occur if necessary. This medication should be stored out of reach of children, and transferring it to other containers should be avoided as it may cause accidents or degrade the quality of the medication.

• Shock
• anaphylactic symptoms
• hypotension
• dyspnea
• laryngeal edema
• urticaria
• pallor
• sweating
• liver dysfunction
• jaundice

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the efficacy of the medication for a longer duration.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle